Pharmaceutical

CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the six months ended June 30, 2026)

CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the six months ended June 30, 2026)

Chugai Pharmaceutical Co., Ltd.July 24, 20265

CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the six months ended June 30, 2026)

About this update from Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd. (4519) Press Release View Attachment

View stock analysis, news, and events for Chugai Pharmaceutical Co., Ltd.

More from Chugai Pharmaceutical Co., Ltd.

F. Hoffmann-La Roche Announces Half Year Results 2026

July 23, 2026

Chugai Pharmaceutical : Alecensa Receives the World-First Tumor-Agnostic Approval for ALK Fusion Gene-Positive Solid Tumors Across Adult ...

May 18, 2026

All Chugai Pharmaceutical Co., Ltd. news →